Claybrook Capital, LLC Albemarle Corp Transaction History
Claybrook Capital, LLC
- $172 Million
- Q3 2023
Shares
2 transactions
Others Institutions Holding ALB
# of Institutions
927Shares Held
104MCall Options Held
8.36MPut Options Held
14.3M-
Vanguard Group Inc Valley Forge, PA14.2MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY9.96MShares$897 Million0.02% of portfolio
-
State Street Corp Boston, MA6.56MShares$590 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$576 Million0.1% of portfolio
-
Primecap Management CO Pasadena, CA3.83MShares$345 Million0.27% of portfolio
About ALBEMARLE CORP
- Ticker ALB
- Exchange NYSE
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 117,129,000
- Market Cap $10.5B
- Description
- Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...